Treatment of Severe Obstructive Sleep Apnea With a Domestic Implantable Hypoglossal Nerve Stimulator: A Case Report
World Journal of Otorhinolaryngology - Head and Neck Surgery · 17.08.2026
DOI: 10.1002/wjo2.70140 ↗Kurz gefasst
Fallbericht in der Zeitschrift World Journal of Otorhinolaryngology - Head and Neck Surgery, online erschienen am 17.08.2026. Verfasst von Su-Ru Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medici…. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Implantable hypoglossal nerve stimulation (HNS) is an established neuromodulatory therapy for obstructive sleep apnea (OSA) in patients intolerant to continuous positive airway pressure (CPAP). However, no domestically developed HNS system has been clinically implemented in China to date.
Methods
We report the first clinical implantation of a novel, Chinese‐developed HNS system in a patient with severe OSA. The patient was a 39‐year‐old man with a 20‐year history of nocturnal snoring and apnea. Preoperative polysomnography (PSG) demonstrated an apnea–hypopnea index (AHI) of 46.3 events per hour and a lowest oxygen saturation of 83%. The device selectively activates the medial branch of the hypoglossal nerve, which induces genioglossus contraction and anterior tongue displacement, thereby stabilizing the upper airway during sleep.
Results
The procedure was successfully performed. At short‐term follow‐up, the patient showed marked improvements: AHI decreased from 46.3 to 11.8 events/hour, LSaO 2 increased from 83% to 86%, and the Epworth Sleepiness Scale Score improved from 1 to 0. No adverse events occurred.
Conclusions
This first‑in‑human experience confirms that the domestic HNS system is feasible, safe, and clinically effective in patient with severe OSA who is intolerant to CPAP. These preliminary results support further clinical development and validation of this domestically manufactured HNS technology for broader application in China.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Sleep Disordered Breathing, Otolaryngol…
ORCID-Profile: Su-Ru Liu, En-Hui Zhou, Shan-Kai Yin
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Liu, S. R., Zhou, E. H., Li, X. Y., Xu, H. J., Guan, J., Yi, H. L., & Yin, S. K. (2026). Treatment of Severe Obstructive Sleep Apnea With a Domestic Implantable Hypoglossal Nerve Stimulator: A Case Report. World Journal of Otorhinolaryngology - Head and Neck Surgery. https://doi.org/10.1002/wjo2.70140
Vancouver
Liu SR, Zhou EH, Li XY, Xu HJ, Guan J, Yi HL, et al. Treatment of Severe Obstructive Sleep Apnea With a Domestic Implantable Hypoglossal Nerve Stimulator: A Case Report. World Journal of Otorhinolaryngology - Head and Neck Surgery. 2026. doi:10.1002/wjo2.70140
BibTeX
@article{Liu2026,
author = {Liu, Su-Ru and Zhou, En-Hui and Li, Xin-Yi and Xu, Hua-Jun and Guan, Jian and Yi, Hong-Liang and Yin, Shan-Kai},
title = {Treatment of Severe Obstructive Sleep Apnea With a Domestic Implantable Hypoglossal Nerve Stimulator: A Case Report},
journal = {World Journal of Otorhinolaryngology - Head and Neck Surgery},
year = {2026},
doi = {10.1002/wjo2.70140}
}
EUVIMED